Top of page Skip navigation
  • SAVE THE DATE

    Thursday 12 October, London

  • SAVE THE DATE

    Thursday 12 October. London

Event Supporters

BBSRC

The Biotechnology and Biological Sciences Research Council (BBSRC) invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, BBSRC invested over £473 million in world-class bioscience in 2015 - 2016.  We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact visit: www.bbsrc.ac.uk

For more information about BBSRC strategically funded institutes visit: www.bbsrc.ac.uk/institutes

 EY

More than any other technology, biotechnology has the potential to alter our lives in a positive way. And by achieving this potential, today’s biotech companies are delivering new levels of health, prosperity and sustainability — across the world.

But with uncertain capital markets, increasing regulation, growing pricing pressures, competition for acquisitions and an evolving health care environment around the world, this sector faces unprecedented challenges.

We have been a pioneering presence in the biotechnology industry. We were the first professional services firm to build a practice dedicated to serving your industry.

We’ve stayed committed to your business with our leading reports and our network of knowledgeable professionals.  So it’s not surprising that we serve more biotech companies than any other professional services firm — by a wide margin.

www.ey.com

 

MSP


Alderley Park has a strong history of drug discovery and development and is set in 400 acres of Cheshire countryside.

A dedicated Life Science Enterprise Zone, it offers 1m sq ft of premier scientific laboratory space and over 400,000 sq ft of office space all accompanied by great retail, leisure and a vibrant social events programme.  Alderley Park is home to over 150 biotech and life science companies and a number of key assets including, the Medicines Discovery Catapult, the translational centre for AMR, a Waters open access lab. It’s community of 3000 people and growing fast makes it a perfect home for your business. The Park is well connected and easily accessible – it’s only 10 miles to Manchester airport, 18 miles to Manchester city centre and great rail links make London less than 2hrs away.

www.mspl.co.uk


Translating research into production

Porton Biopharma Limited was established earlier this year to commercialise the pharmaceutical development and manufacturing capabilities at the Porton Down site in Wiltshire that were previously within Public Health England.

We develop new vaccines, therapeutic proteins and enzyme products, and also manufacture our own licensed biopharmaceutical products, Erwinase® and Anthrax Vaccine (alum precipitated sterile filtrate). With specialist expertise in the development of both manufacturing and analytical processes for use with biological pharmaceutical products. As well as undertaking contract manufacture at all stages of the product development/commercialisation lifecycle, we can help you successfully develop your product.

www.portonbiopharma.com

 

Potter Clarkson LLP is an award winning firm top tier of European patent and trade mark attorneys. The firm advises clients worldwide on patents, trademarks, designs and associated aspects of intellectual property.  The 145 strong team includes over 55 patent and trade mark professionals working together at a single site in Nottingham.  Their technical qualifications and experience are outstanding.  Specialist sectors include: Biotechnology and Pharmaceuticals; Chemistry; Designs and Engineering; Electronics and Computing; and Energy and Clean Technologies. 

www.potterclarkson.com

 

PHE

 

Public Health England (PHE) is a new Executive Agency of the UK Department of Health that is responsible for protecting and improving the nation’s health and wellbeing and reducing inequalities. With ~6000 staff and £1 billion operational budget, we provide a nationwide, integrated public health service supporting people to make healthier choices and providing expertise, information and intelligence. Our translational research, development and testing programmes focus on diagnostics, vaccines and other interventions across healthcare and public health.


www.gov.uk/phe

 

RSA is the world’s largest talent consultancy in life sciences, advising on the selection, assessment and onboarding of Board and Senior Executive Talent. We specialise in performing due diligence on talent helping you make Better Decisions for Better People. We do this by using a unique Proof of Candidate® approach which is based on evidence and in-depth comparative analysis. With offices in USA, UK, Belgium, Germany, Austria, Switzerland, Turkey, Singapore and China we are large enough to be global but small enough to remain focused on you. 

www.thersagroup.com

 Stratagem

Stratagem Intellectual Property Management Ltd is a full-service, Cambridge UK-based, out sourced intellectual organisation and management company with global reach.

Stratagem IPM Ltd fills a developing need within industry for the provision of strategic advice and intellectual property management for life science, medtech, cleantech and high technology companies.  Stratagem’s qualified patent and trade mark attorneys use a commercial perspective and hands on management approach to enhance the value of IP assets.

www.stratagemipm.co.uk